Table 1.
Cases report of Trichosporon japonicum infections, review of literature (including the present case).
| Age | Gender | Comorbidity Conditions |
Clinical Presentation |
Site of Positive Culture |
Treatment | Outcome | Reference | |
|---|---|---|---|---|---|---|---|---|
| Molecule | Duration | |||||||
| 8 | F | AML | Respiratory distress | Sputum | AMB-L (5 mg/kg/D) + ITRA (100 mg/D) | NS | Death | [9] |
| - | - | - | Hypersensitivity pneumonitis | BALF | - | - | - | [10] |
| 18 | F | Transcutaneous biventricular assist device | Fungemia | Blood, aortic cannula, removed left ventricular apex cuff | AMB-L + 5FC switch VORI |
11 days / 6 weeks |
Survival at 2 months | [6] |
| 36 | M | Kidney transplant recipient | Urinary tract infection | Urine | VORI + CASPO | NS | Survival | [8] |
| 50 | M | Kidney transplant recipient | Urinary tract infection | Urine | VORI + CASPO | 15 days | Death | [8] |
| 8 | M | ALL | Fungemia | Blood | AMB (3 mg/kg/D) + VORI (8 mg/kg twice a day) | 11 days | Death | [7] |
| 42 | F | Heart transplant recipient | Pericardial effusion | Pericardial fluid | AMB-L (1.5 mg/kg/D) | 6 days | Death | Present case |
AML: Acute Myeloid Leukemia; ALL: acute B cell lymphoblastic leukemia; F: Female; M: Male; D: day; BALF: Broncho alveolar lavage fluid; AMB-L: Liposomal amphotericin B; ITRA: itraconazole; 5FC: 5-fluorocytosine; CASPO: caspofungin; VORI: voriconazole; NS: Not Specified.